Trump signals major tariff on pharma imports, Indian drugmakers could face impact

Donald Trump announced a forthcoming “major” tariff on pharmaceutical imports, aiming to incentivize drug companies to relocate operations to the U.S. He also stated he warned Taiwan Semiconductor Manufacturing Company (TSMC) about potential taxes if they didn’t establish U.S. plants. Trump criticized the Biden administration’s $6.6 billion grant to TSMC’s U.S.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *